VLADIMIR MATHIEU: Open Payments
NPI 1437212719 · NAPLES, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$7,640 in 122 payments from 23 companies in 2025. Trend: 2023 $4,382 · 2024 $5,115 · 2025 $7,640
Food & beverage: $4,380Consulting: $1,705Travel & lodging: $1,554
| Company | Payments | Amount |
|---|---|---|
| Eisai Inc. | 11 | $3,708 |
| AstraZeneca Pharmaceuticals LP | 19 | $763 |
| Novo Nordisk Inc | 24 | $745 |
| ABBVIE INC. | 5 | $416 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 5 | $387 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 5 | $196 |
| Lilly USA, LLC | 4 | $189 |
| Phathom Pharmaceuticals, Inc. | 4 | $180 |
| Novartis Pharmaceuticals Corporation | 7 | $163 |
| Amgen Inc. | 9 | $147 |
Products named: Leqembi, JARDIANCE, Ozempic, VRAYLAR, FARXIGA, AIRSUPRA, Wegovy, CAPLYTA.
Industry payments across FL — which companies pay providers there.
